nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CHRM3—muscle of abdomen—muscle cancer	0.0119	0.309	CbGeAlD
Tramadol—OPRD1—renal system—muscle cancer	0.0026	0.0675	CbGeAlD
Tramadol—GRIN3A—head—muscle cancer	0.00247	0.0641	CbGeAlD
Tramadol—GRIN3A—testis—muscle cancer	0.00239	0.0619	CbGeAlD
Tramadol—OPRD1—head—muscle cancer	0.00174	0.0452	CbGeAlD
Tramadol—OPRK1—head—muscle cancer	0.00167	0.0433	CbGeAlD
Tramadol—CHRM3—smooth muscle tissue—muscle cancer	0.00137	0.0354	CbGeAlD
Tramadol—CHRM3—renal system—muscle cancer	0.00132	0.0341	CbGeAlD
Tramadol—Thrombocytopenia—Etoposide—muscle cancer	0.0012	0.00125	CcSEcCtD
Tramadol—Upper respiratory tract infection—Methotrexate—muscle cancer	0.0012	0.00125	CcSEcCtD
Tramadol—Tachycardia—Etoposide—muscle cancer	0.0012	0.00125	CcSEcCtD
Tramadol—Abdominal pain—Vincristine—muscle cancer	0.0012	0.00125	CcSEcCtD
Tramadol—Body temperature increased—Vincristine—muscle cancer	0.0012	0.00125	CcSEcCtD
Tramadol—Liver function test abnormal—Doxorubicin—muscle cancer	0.0012	0.00125	CcSEcCtD
Tramadol—Skin disorder—Etoposide—muscle cancer	0.00119	0.00124	CcSEcCtD
Tramadol—Erectile dysfunction—Methotrexate—muscle cancer	0.00119	0.00124	CcSEcCtD
Tramadol—Dry skin—Doxorubicin—muscle cancer	0.00119	0.00124	CcSEcCtD
Tramadol—Hyperhidrosis—Etoposide—muscle cancer	0.00119	0.00124	CcSEcCtD
Tramadol—OPRM1—head—muscle cancer	0.00119	0.0308	CbGeAlD
Tramadol—Abdominal pain upper—Doxorubicin—muscle cancer	0.00119	0.00123	CcSEcCtD
Tramadol—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00119	0.00123	CcSEcCtD
Tramadol—Photosensitivity reaction—Methotrexate—muscle cancer	0.00118	0.00123	CcSEcCtD
Tramadol—Hypokalaemia—Doxorubicin—muscle cancer	0.00118	0.00123	CcSEcCtD
Tramadol—Breast disorder—Doxorubicin—muscle cancer	0.00117	0.00122	CcSEcCtD
Tramadol—Anorexia—Etoposide—muscle cancer	0.00117	0.00122	CcSEcCtD
Tramadol—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00117	0.00122	CcSEcCtD
Tramadol—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00117	0.00122	CcSEcCtD
Tramadol—Diarrhoea—Dactinomycin—muscle cancer	0.00116	0.00121	CcSEcCtD
Tramadol—Pneumonia—Methotrexate—muscle cancer	0.00116	0.00121	CcSEcCtD
Tramadol—Nasopharyngitis—Doxorubicin—muscle cancer	0.00116	0.00121	CcSEcCtD
Tramadol—Infestation—Methotrexate—muscle cancer	0.00116	0.0012	CcSEcCtD
Tramadol—Infestation NOS—Methotrexate—muscle cancer	0.00116	0.0012	CcSEcCtD
Tramadol—Depression—Methotrexate—muscle cancer	0.00115	0.0012	CcSEcCtD
Tramadol—Hypotension—Etoposide—muscle cancer	0.00115	0.0012	CcSEcCtD
Tramadol—Gastritis—Doxorubicin—muscle cancer	0.00115	0.00119	CcSEcCtD
Tramadol—OPRM1—testis—muscle cancer	0.00115	0.0297	CbGeAlD
Tramadol—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00115	0.00119	CcSEcCtD
Tramadol—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00114	0.00119	CcSEcCtD
Tramadol—Muscular weakness—Doxorubicin—muscle cancer	0.00114	0.00119	CcSEcCtD
Tramadol—Renal failure—Methotrexate—muscle cancer	0.00114	0.00118	CcSEcCtD
Tramadol—Abdominal distension—Doxorubicin—muscle cancer	0.00113	0.00117	CcSEcCtD
Tramadol—Stomatitis—Methotrexate—muscle cancer	0.00113	0.00117	CcSEcCtD
Tramadol—Conjunctivitis—Methotrexate—muscle cancer	0.00112	0.00117	CcSEcCtD
Tramadol—Dysphagia—Doxorubicin—muscle cancer	0.00112	0.00117	CcSEcCtD
Tramadol—Influenza—Doxorubicin—muscle cancer	0.00112	0.00117	CcSEcCtD
Tramadol—Asthma—Doxorubicin—muscle cancer	0.00112	0.00117	CcSEcCtD
Tramadol—Hypersensitivity—Vincristine—muscle cancer	0.00112	0.00116	CcSEcCtD
Tramadol—Sweating—Methotrexate—muscle cancer	0.00111	0.00115	CcSEcCtD
Tramadol—Paraesthesia—Etoposide—muscle cancer	0.0011	0.00115	CcSEcCtD
Tramadol—Haematuria—Methotrexate—muscle cancer	0.0011	0.00115	CcSEcCtD
Tramadol—Pancreatitis—Doxorubicin—muscle cancer	0.0011	0.00114	CcSEcCtD
Tramadol—Dyspnoea—Etoposide—muscle cancer	0.0011	0.00114	CcSEcCtD
Tramadol—Somnolence—Etoposide—muscle cancer	0.00109	0.00114	CcSEcCtD
Tramadol—Angina pectoris—Doxorubicin—muscle cancer	0.00109	0.00114	CcSEcCtD
Tramadol—Hepatobiliary disease—Methotrexate—muscle cancer	0.00109	0.00114	CcSEcCtD
Tramadol—Epistaxis—Methotrexate—muscle cancer	0.00109	0.00113	CcSEcCtD
Tramadol—Asthenia—Vincristine—muscle cancer	0.00109	0.00113	CcSEcCtD
Tramadol—Vomiting—Dactinomycin—muscle cancer	0.00108	0.00112	CcSEcCtD
Tramadol—Bronchitis—Doxorubicin—muscle cancer	0.00108	0.00112	CcSEcCtD
Tramadol—Rash—Dactinomycin—muscle cancer	0.00107	0.00111	CcSEcCtD
Tramadol—Decreased appetite—Etoposide—muscle cancer	0.00107	0.00111	CcSEcCtD
Tramadol—Gastrointestinal disorder—Etoposide—muscle cancer	0.00106	0.0011	CcSEcCtD
Tramadol—Fatigue—Etoposide—muscle cancer	0.00106	0.0011	CcSEcCtD
Tramadol—Pain—Etoposide—muscle cancer	0.00105	0.00109	CcSEcCtD
Tramadol—Constipation—Etoposide—muscle cancer	0.00105	0.00109	CcSEcCtD
Tramadol—Dysuria—Doxorubicin—muscle cancer	0.00105	0.00109	CcSEcCtD
Tramadol—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00104	0.00108	CcSEcCtD
Tramadol—Haemoglobin—Methotrexate—muscle cancer	0.00104	0.00108	CcSEcCtD
Tramadol—HTR2C—head—muscle cancer	0.00104	0.027	CbGeAlD
Tramadol—Diarrhoea—Vincristine—muscle cancer	0.00104	0.00108	CcSEcCtD
Tramadol—Haemorrhage—Methotrexate—muscle cancer	0.00104	0.00108	CcSEcCtD
Tramadol—Hepatitis—Methotrexate—muscle cancer	0.00104	0.00108	CcSEcCtD
Tramadol—Pollakiuria—Doxorubicin—muscle cancer	0.00104	0.00108	CcSEcCtD
Tramadol—Pharyngitis—Methotrexate—muscle cancer	0.00103	0.00107	CcSEcCtD
Tramadol—Urinary tract disorder—Methotrexate—muscle cancer	0.00102	0.00107	CcSEcCtD
Tramadol—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00102	0.00107	CcSEcCtD
Tramadol—Urethral disorder—Methotrexate—muscle cancer	0.00102	0.00106	CcSEcCtD
Tramadol—Weight decreased—Doxorubicin—muscle cancer	0.00101	0.00106	CcSEcCtD
Tramadol—Feeling abnormal—Etoposide—muscle cancer	0.00101	0.00105	CcSEcCtD
Tramadol—Hyperglycaemia—Doxorubicin—muscle cancer	0.00101	0.00105	CcSEcCtD
Tramadol—Nausea—Dactinomycin—muscle cancer	0.00101	0.00105	CcSEcCtD
Tramadol—Pneumonia—Doxorubicin—muscle cancer	0.00101	0.00105	CcSEcCtD
Tramadol—Gastrointestinal pain—Etoposide—muscle cancer	0.00101	0.00105	CcSEcCtD
Tramadol—Dizziness—Vincristine—muscle cancer	0.001	0.00104	CcSEcCtD
Tramadol—Infestation NOS—Doxorubicin—muscle cancer	0.001	0.00104	CcSEcCtD
Tramadol—Infestation—Doxorubicin—muscle cancer	0.001	0.00104	CcSEcCtD
Tramadol—Visual impairment—Methotrexate—muscle cancer	0.000999	0.00104	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000992	0.00103	CcSEcCtD
Tramadol—SLC6A4—head—muscle cancer	0.000987	0.0256	CbGeAlD
Tramadol—Renal failure—Doxorubicin—muscle cancer	0.000983	0.00102	CcSEcCtD
Tramadol—Erythema multiforme—Methotrexate—muscle cancer	0.000981	0.00102	CcSEcCtD
Tramadol—Urticaria—Etoposide—muscle cancer	0.000977	0.00102	CcSEcCtD
Tramadol—Stomatitis—Doxorubicin—muscle cancer	0.000975	0.00101	CcSEcCtD
Tramadol—Abdominal pain—Etoposide—muscle cancer	0.000972	0.00101	CcSEcCtD
Tramadol—Body temperature increased—Etoposide—muscle cancer	0.000972	0.00101	CcSEcCtD
Tramadol—Urinary tract infection—Doxorubicin—muscle cancer	0.000972	0.00101	CcSEcCtD
Tramadol—Conjunctivitis—Doxorubicin—muscle cancer	0.000972	0.00101	CcSEcCtD
Tramadol—Eye disorder—Methotrexate—muscle cancer	0.000969	0.00101	CcSEcCtD
Tramadol—Tinnitus—Methotrexate—muscle cancer	0.000967	0.00101	CcSEcCtD
Tramadol—Vomiting—Vincristine—muscle cancer	0.000965	0.001	CcSEcCtD
Tramadol—Cardiac disorder—Methotrexate—muscle cancer	0.000962	0.001	CcSEcCtD
Tramadol—Sweating—Doxorubicin—muscle cancer	0.000959	0.000997	CcSEcCtD
Tramadol—Rash—Vincristine—muscle cancer	0.000957	0.000996	CcSEcCtD
Tramadol—CYP2B6—renal system—muscle cancer	0.000957	0.0248	CbGeAlD
Tramadol—Dermatitis—Vincristine—muscle cancer	0.000956	0.000995	CcSEcCtD
Tramadol—Haematuria—Doxorubicin—muscle cancer	0.000954	0.000992	CcSEcCtD
Tramadol—Headache—Vincristine—muscle cancer	0.000951	0.000989	CcSEcCtD
Tramadol—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000946	0.000984	CcSEcCtD
Tramadol—Epistaxis—Doxorubicin—muscle cancer	0.000943	0.000981	CcSEcCtD
Tramadol—Angiopathy—Methotrexate—muscle cancer	0.000941	0.000979	CcSEcCtD
Tramadol—Sinusitis—Doxorubicin—muscle cancer	0.000938	0.000976	CcSEcCtD
Tramadol—Immune system disorder—Methotrexate—muscle cancer	0.000937	0.000974	CcSEcCtD
Tramadol—Mediastinal disorder—Methotrexate—muscle cancer	0.000935	0.000972	CcSEcCtD
Tramadol—Chills—Methotrexate—muscle cancer	0.00093	0.000968	CcSEcCtD
Tramadol—Bradycardia—Doxorubicin—muscle cancer	0.000914	0.000951	CcSEcCtD
Tramadol—Mental disorder—Methotrexate—muscle cancer	0.000909	0.000945	CcSEcCtD
Tramadol—Hypersensitivity—Etoposide—muscle cancer	0.000906	0.000943	CcSEcCtD
Tramadol—Malnutrition—Methotrexate—muscle cancer	0.000903	0.000939	CcSEcCtD
Tramadol—Erythema—Methotrexate—muscle cancer	0.000903	0.000939	CcSEcCtD
Tramadol—Haemoglobin—Doxorubicin—muscle cancer	0.000903	0.000939	CcSEcCtD
Tramadol—Nausea—Vincristine—muscle cancer	0.000902	0.000938	CcSEcCtD
Tramadol—Rhinitis—Doxorubicin—muscle cancer	0.0009	0.000936	CcSEcCtD
Tramadol—Haemorrhage—Doxorubicin—muscle cancer	0.000898	0.000934	CcSEcCtD
Tramadol—Hepatitis—Doxorubicin—muscle cancer	0.000898	0.000934	CcSEcCtD
Tramadol—Hypoaesthesia—Doxorubicin—muscle cancer	0.000893	0.000929	CcSEcCtD
Tramadol—Pharyngitis—Doxorubicin—muscle cancer	0.000891	0.000927	CcSEcCtD
Tramadol—Urinary tract disorder—Doxorubicin—muscle cancer	0.000887	0.000922	CcSEcCtD
Tramadol—Oedema peripheral—Doxorubicin—muscle cancer	0.000885	0.00092	CcSEcCtD
Tramadol—Dysgeusia—Methotrexate—muscle cancer	0.000884	0.000919	CcSEcCtD
Tramadol—Asthenia—Etoposide—muscle cancer	0.000883	0.000918	CcSEcCtD
Tramadol—Connective tissue disorder—Doxorubicin—muscle cancer	0.000882	0.000918	CcSEcCtD
Tramadol—Urethral disorder—Doxorubicin—muscle cancer	0.00088	0.000916	CcSEcCtD
Tramadol—CHRM3—head—muscle cancer	0.00088	0.0228	CbGeAlD
Tramadol—Back pain—Methotrexate—muscle cancer	0.000873	0.000908	CcSEcCtD
Tramadol—Pruritus—Etoposide—muscle cancer	0.00087	0.000905	CcSEcCtD
Tramadol—SLC6A2—head—muscle cancer	0.000869	0.0225	CbGeAlD
Tramadol—Visual impairment—Doxorubicin—muscle cancer	0.000865	0.0009	CcSEcCtD
Tramadol—Vision blurred—Methotrexate—muscle cancer	0.000851	0.000885	CcSEcCtD
Tramadol—CHRM3—testis—muscle cancer	0.00085	0.0221	CbGeAlD
Tramadol—Erythema multiforme—Doxorubicin—muscle cancer	0.000849	0.000883	CcSEcCtD
Tramadol—Diarrhoea—Etoposide—muscle cancer	0.000842	0.000875	CcSEcCtD
Tramadol—SLC6A2—testis—muscle cancer	0.00084	0.0218	CbGeAlD
Tramadol—Eye disorder—Doxorubicin—muscle cancer	0.000839	0.000873	CcSEcCtD
Tramadol—Ill-defined disorder—Methotrexate—muscle cancer	0.000838	0.000871	CcSEcCtD
Tramadol—Tinnitus—Doxorubicin—muscle cancer	0.000837	0.000871	CcSEcCtD
Tramadol—Anaemia—Methotrexate—muscle cancer	0.000834	0.000868	CcSEcCtD
Tramadol—Flushing—Doxorubicin—muscle cancer	0.000833	0.000867	CcSEcCtD
Tramadol—Cardiac disorder—Doxorubicin—muscle cancer	0.000833	0.000867	CcSEcCtD
Tramadol—Angiopathy—Doxorubicin—muscle cancer	0.000815	0.000847	CcSEcCtD
Tramadol—Malaise—Methotrexate—muscle cancer	0.000814	0.000847	CcSEcCtD
Tramadol—Dizziness—Etoposide—muscle cancer	0.000813	0.000846	CcSEcCtD
Tramadol—Immune system disorder—Doxorubicin—muscle cancer	0.000811	0.000844	CcSEcCtD
Tramadol—Vertigo—Methotrexate—muscle cancer	0.000811	0.000844	CcSEcCtD
Tramadol—Mediastinal disorder—Doxorubicin—muscle cancer	0.000809	0.000842	CcSEcCtD
Tramadol—Chills—Doxorubicin—muscle cancer	0.000806	0.000838	CcSEcCtD
Tramadol—Arrhythmia—Doxorubicin—muscle cancer	0.000802	0.000834	CcSEcCtD
Tramadol—Cough—Methotrexate—muscle cancer	0.000788	0.000819	CcSEcCtD
Tramadol—Mental disorder—Doxorubicin—muscle cancer	0.000787	0.000818	CcSEcCtD
Tramadol—Convulsion—Methotrexate—muscle cancer	0.000782	0.000814	CcSEcCtD
Tramadol—Vomiting—Etoposide—muscle cancer	0.000782	0.000813	CcSEcCtD
Tramadol—Erythema—Doxorubicin—muscle cancer	0.000782	0.000813	CcSEcCtD
Tramadol—Malnutrition—Doxorubicin—muscle cancer	0.000782	0.000813	CcSEcCtD
Tramadol—Rash—Etoposide—muscle cancer	0.000776	0.000807	CcSEcCtD
Tramadol—Dermatitis—Etoposide—muscle cancer	0.000775	0.000806	CcSEcCtD
Tramadol—Headache—Etoposide—muscle cancer	0.000771	0.000801	CcSEcCtD
Tramadol—Flatulence—Doxorubicin—muscle cancer	0.00077	0.000801	CcSEcCtD
Tramadol—Arthralgia—Methotrexate—muscle cancer	0.000769	0.000799	CcSEcCtD
Tramadol—Chest pain—Methotrexate—muscle cancer	0.000769	0.000799	CcSEcCtD
Tramadol—Myalgia—Methotrexate—muscle cancer	0.000769	0.000799	CcSEcCtD
Tramadol—Tension—Doxorubicin—muscle cancer	0.000767	0.000798	CcSEcCtD
Tramadol—Dysgeusia—Doxorubicin—muscle cancer	0.000765	0.000796	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000763	0.000794	CcSEcCtD
Tramadol—Discomfort—Methotrexate—muscle cancer	0.000759	0.00079	CcSEcCtD
Tramadol—Nervousness—Doxorubicin—muscle cancer	0.000759	0.00079	CcSEcCtD
Tramadol—Back pain—Doxorubicin—muscle cancer	0.000756	0.000786	CcSEcCtD
Tramadol—Muscle spasms—Doxorubicin—muscle cancer	0.000752	0.000782	CcSEcCtD
Tramadol—Confusional state—Methotrexate—muscle cancer	0.000743	0.000773	CcSEcCtD
Tramadol—Anaphylactic shock—Methotrexate—muscle cancer	0.000737	0.000766	CcSEcCtD
Tramadol—Vision blurred—Doxorubicin—muscle cancer	0.000737	0.000766	CcSEcCtD
Tramadol—Infection—Methotrexate—muscle cancer	0.000732	0.000761	CcSEcCtD
Tramadol—Nausea—Etoposide—muscle cancer	0.000731	0.00076	CcSEcCtD
Tramadol—Ill-defined disorder—Doxorubicin—muscle cancer	0.000725	0.000754	CcSEcCtD
Tramadol—CYP3A4—renal system—muscle cancer	0.000723	0.0188	CbGeAlD
Tramadol—Nervous system disorder—Methotrexate—muscle cancer	0.000723	0.000751	CcSEcCtD
Tramadol—Anaemia—Doxorubicin—muscle cancer	0.000722	0.000751	CcSEcCtD
Tramadol—Thrombocytopenia—Methotrexate—muscle cancer	0.000721	0.00075	CcSEcCtD
Tramadol—Agitation—Doxorubicin—muscle cancer	0.000718	0.000747	CcSEcCtD
Tramadol—Skin disorder—Methotrexate—muscle cancer	0.000716	0.000744	CcSEcCtD
Tramadol—Hyperhidrosis—Methotrexate—muscle cancer	0.000712	0.000741	CcSEcCtD
Tramadol—CYP2D6—renal system—muscle cancer	0.000711	0.0185	CbGeAlD
Tramadol—Malaise—Doxorubicin—muscle cancer	0.000705	0.000733	CcSEcCtD
Tramadol—Vertigo—Doxorubicin—muscle cancer	0.000702	0.00073	CcSEcCtD
Tramadol—Anorexia—Methotrexate—muscle cancer	0.000702	0.00073	CcSEcCtD
Tramadol—Syncope—Doxorubicin—muscle cancer	0.000701	0.000729	CcSEcCtD
Tramadol—CYP2B6—vagina—muscle cancer	0.000693	0.018	CbGeAlD
Tramadol—Palpitations—Doxorubicin—muscle cancer	0.000691	0.000718	CcSEcCtD
Tramadol—Hypotension—Methotrexate—muscle cancer	0.000688	0.000716	CcSEcCtD
Tramadol—Loss of consciousness—Doxorubicin—muscle cancer	0.000687	0.000715	CcSEcCtD
Tramadol—Cough—Doxorubicin—muscle cancer	0.000682	0.000709	CcSEcCtD
Tramadol—Convulsion—Doxorubicin—muscle cancer	0.000677	0.000704	CcSEcCtD
Tramadol—Hypertension—Doxorubicin—muscle cancer	0.000675	0.000702	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000671	0.000698	CcSEcCtD
Tramadol—Insomnia—Methotrexate—muscle cancer	0.000666	0.000693	CcSEcCtD
Tramadol—Myalgia—Doxorubicin—muscle cancer	0.000665	0.000692	CcSEcCtD
Tramadol—Chest pain—Doxorubicin—muscle cancer	0.000665	0.000692	CcSEcCtD
Tramadol—Arthralgia—Doxorubicin—muscle cancer	0.000665	0.000692	CcSEcCtD
Tramadol—Anxiety—Doxorubicin—muscle cancer	0.000663	0.00069	CcSEcCtD
Tramadol—Paraesthesia—Methotrexate—muscle cancer	0.000662	0.000688	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000661	0.000687	CcSEcCtD
Tramadol—Discomfort—Doxorubicin—muscle cancer	0.000658	0.000684	CcSEcCtD
Tramadol—Dyspnoea—Methotrexate—muscle cancer	0.000657	0.000683	CcSEcCtD
Tramadol—Somnolence—Methotrexate—muscle cancer	0.000655	0.000681	CcSEcCtD
Tramadol—Dry mouth—Doxorubicin—muscle cancer	0.000651	0.000677	CcSEcCtD
Tramadol—Dyspepsia—Methotrexate—muscle cancer	0.000649	0.000675	CcSEcCtD
Tramadol—Confusional state—Doxorubicin—muscle cancer	0.000643	0.000669	CcSEcCtD
Tramadol—CYP2B6—head—muscle cancer	0.00064	0.0166	CbGeAlD
Tramadol—Decreased appetite—Methotrexate—muscle cancer	0.00064	0.000666	CcSEcCtD
Tramadol—Anaphylactic shock—Doxorubicin—muscle cancer	0.000638	0.000664	CcSEcCtD
Tramadol—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000636	0.000662	CcSEcCtD
Tramadol—Fatigue—Methotrexate—muscle cancer	0.000635	0.000661	CcSEcCtD
Tramadol—Infection—Doxorubicin—muscle cancer	0.000634	0.000659	CcSEcCtD
Tramadol—Pain—Methotrexate—muscle cancer	0.00063	0.000655	CcSEcCtD
Tramadol—Shock—Doxorubicin—muscle cancer	0.000628	0.000653	CcSEcCtD
Tramadol—Nervous system disorder—Doxorubicin—muscle cancer	0.000626	0.000651	CcSEcCtD
Tramadol—Thrombocytopenia—Doxorubicin—muscle cancer	0.000625	0.00065	CcSEcCtD
Tramadol—Tachycardia—Doxorubicin—muscle cancer	0.000623	0.000648	CcSEcCtD
Tramadol—Skin disorder—Doxorubicin—muscle cancer	0.00062	0.000645	CcSEcCtD
Tramadol—CYP2B6—testis—muscle cancer	0.000619	0.0161	CbGeAlD
Tramadol—Hyperhidrosis—Doxorubicin—muscle cancer	0.000617	0.000641	CcSEcCtD
Tramadol—Anorexia—Doxorubicin—muscle cancer	0.000608	0.000632	CcSEcCtD
Tramadol—Feeling abnormal—Methotrexate—muscle cancer	0.000607	0.000631	CcSEcCtD
Tramadol—Gastrointestinal pain—Methotrexate—muscle cancer	0.000602	0.000627	CcSEcCtD
Tramadol—Hypotension—Doxorubicin—muscle cancer	0.000596	0.00062	CcSEcCtD
Tramadol—Urticaria—Methotrexate—muscle cancer	0.000585	0.000609	CcSEcCtD
Tramadol—Abdominal pain—Methotrexate—muscle cancer	0.000582	0.000606	CcSEcCtD
Tramadol—Body temperature increased—Methotrexate—muscle cancer	0.000582	0.000606	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000581	0.000605	CcSEcCtD
Tramadol—Insomnia—Doxorubicin—muscle cancer	0.000577	0.0006	CcSEcCtD
Tramadol—Paraesthesia—Doxorubicin—muscle cancer	0.000573	0.000596	CcSEcCtD
Tramadol—Dyspnoea—Doxorubicin—muscle cancer	0.000569	0.000592	CcSEcCtD
Tramadol—Somnolence—Doxorubicin—muscle cancer	0.000567	0.00059	CcSEcCtD
Tramadol—Dyspepsia—Doxorubicin—muscle cancer	0.000562	0.000584	CcSEcCtD
Tramadol—Decreased appetite—Doxorubicin—muscle cancer	0.000555	0.000577	CcSEcCtD
Tramadol—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000551	0.000573	CcSEcCtD
Tramadol—Fatigue—Doxorubicin—muscle cancer	0.00055	0.000572	CcSEcCtD
Tramadol—Constipation—Doxorubicin—muscle cancer	0.000546	0.000567	CcSEcCtD
Tramadol—Pain—Doxorubicin—muscle cancer	0.000546	0.000567	CcSEcCtD
Tramadol—Hypersensitivity—Methotrexate—muscle cancer	0.000543	0.000565	CcSEcCtD
Tramadol—Asthenia—Methotrexate—muscle cancer	0.000529	0.00055	CcSEcCtD
Tramadol—Feeling abnormal—Doxorubicin—muscle cancer	0.000526	0.000547	CcSEcCtD
Tramadol—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000522	0.000543	CcSEcCtD
Tramadol—Pruritus—Methotrexate—muscle cancer	0.000521	0.000542	CcSEcCtD
Tramadol—Urticaria—Doxorubicin—muscle cancer	0.000507	0.000527	CcSEcCtD
Tramadol—Abdominal pain—Doxorubicin—muscle cancer	0.000504	0.000525	CcSEcCtD
Tramadol—Body temperature increased—Doxorubicin—muscle cancer	0.000504	0.000525	CcSEcCtD
Tramadol—Diarrhoea—Methotrexate—muscle cancer	0.000504	0.000524	CcSEcCtD
Tramadol—Dizziness—Methotrexate—muscle cancer	0.000487	0.000507	CcSEcCtD
Tramadol—CYP2D6—head—muscle cancer	0.000476	0.0123	CbGeAlD
Tramadol—Hypersensitivity—Doxorubicin—muscle cancer	0.00047	0.000489	CcSEcCtD
Tramadol—Vomiting—Methotrexate—muscle cancer	0.000468	0.000487	CcSEcCtD
Tramadol—Rash—Methotrexate—muscle cancer	0.000465	0.000483	CcSEcCtD
Tramadol—Dermatitis—Methotrexate—muscle cancer	0.000464	0.000483	CcSEcCtD
Tramadol—Headache—Methotrexate—muscle cancer	0.000462	0.00048	CcSEcCtD
Tramadol—CYP2D6—testis—muscle cancer	0.00046	0.0119	CbGeAlD
Tramadol—Asthenia—Doxorubicin—muscle cancer	0.000458	0.000476	CcSEcCtD
Tramadol—Pruritus—Doxorubicin—muscle cancer	0.000451	0.000469	CcSEcCtD
Tramadol—Nausea—Methotrexate—muscle cancer	0.000438	0.000455	CcSEcCtD
Tramadol—Diarrhoea—Doxorubicin—muscle cancer	0.000436	0.000454	CcSEcCtD
Tramadol—Dizziness—Doxorubicin—muscle cancer	0.000422	0.000439	CcSEcCtD
Tramadol—Vomiting—Doxorubicin—muscle cancer	0.000406	0.000422	CcSEcCtD
Tramadol—Rash—Doxorubicin—muscle cancer	0.000402	0.000418	CcSEcCtD
Tramadol—Dermatitis—Doxorubicin—muscle cancer	0.000402	0.000418	CcSEcCtD
Tramadol—Headache—Doxorubicin—muscle cancer	0.0004	0.000416	CcSEcCtD
Tramadol—Nausea—Doxorubicin—muscle cancer	0.000379	0.000394	CcSEcCtD
